The Management of Locally Advanced Carcinoma of the Oesophagus - SCOPE for Improvement?

Clinical Oncology

Volumn 21, Issue 4, 2009, Pages 281-284

  Crosby, T D L ^a   Evans, M ^a  

^a VELINDRE CANCER CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CETUXIMAB;

ADVANCED CANCER; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; EDITORIAL; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; HUMAN; ORAL MUCOSAL DISEASE; PRIORITY JOURNAL; QUALITY OF LIFE; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; HUMANS; QUALITY OF LIFE; RADIOTHERAPY, ADJUVANT;

EID: 62849092937     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2009.01.007     Document Type: Editorial

References (30)

1. Cancer Research UK. Survival - England and Wales. Available from: (2004). http://publications.cancerresearchuk.org/epages/crukstore.sf/en_GB/?Obje ctPath=/Shops/crukstore/Products/CSSURV04
2. Crosby T. Scottish Intercollegiate Guidelines Network (SIGN) 87 - the management of oesophageal and gastric cancer. Clin Oncol 20 (2008) 528-529
3. MRC OE05: Perioperative chemotherapy in patients with oesophageal adenocarcinoma. Available from:. http://www.ctu.mrc.ac.uk/studies/OE05.asp
4. Medical Research Council Oesophageal Cancer Working Group. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet 359 9319 (2002) 1727-1733
5. Blazeby J., Farndon J., Donovan J., and Alderson D. A prospective longitudinal study examining the quality of life of patients with esophageal carcinoma. Cancer 88 (2000) 1781-1787
6. Allum WH, Fogarty PJ, Stenning SP, Langley RE, NCRI Upper GI Cancer Clinical Studies Group. Long term results of the MRC OEO2 randomized trial of surgery with or without preoperative chemotherapy in resectable esophageal cancer. ASCO Gastrointestinal Cancer Symposium 2008, [abstract 9].
7. Cooper J.S., Guo M.D., Herskovic A., et al. Chemotherapy of locally advanced esophageal cancer: long term follow-up of a prospective randomized trial (RTOG 85-01). JAMA 281 (1999) 1623-1627
8. Wong R., and Malthaner R. Combined chemotherapy and radiotherapy (without surgery) compared with radiotherapy alone in localized carcinoma of the esophagus (Cochrane Review). The Cochrane Library, Issue 1 (2006), Update Software, Oxford
9. Minsky B.D., Pajak T.F., Ginsberg R.J., et al. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol 20 5 (2002) 1167-1174
10. Stahl M., Stuschke M., Lehmann N., et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 23 (2005) 2310-2317
11. Bedenne L., Michel P., Bouche O., et al. Randomized phase III trial in locally advanced esophageal cancer: radiochemotherapy followed by surgery versus radiochemotherapy alone (FFCD 9102). J Clin Oncol 25 (2007) 1160-1168
12. Crosby T.D., Brewster A.E., Borley A., et al. Definitive chemoradiation in patients with inoperable oesophageal carcinoma. Br J Cancer 90 (2004) 70-75
13. Urschel J.D., and Vasan H. A meta-analysis of randomised controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am J Surg 185 (2003) 538-543
14. Fiorica F., Di Bona D., Schepis F., et al. Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis. Gut 53 (2004) 925-930
15. Kelsen D.P., Ginsberg R., Pajak T.F., et al. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 339 (1998) 1979-1984
16. Borghesi S., Hawkins M.A., and Tait D. Oesophagectomy after definitive chemoradiation in patients with locally advanced oesophageal cancer. Clin Oncol 20 (2008) 221-226
17. Lagergren P., Avery K.N.L., Hughes R., et al. Health-related quality of life among patients cured by surgery for esophageal cancer. Cancer 110 (2007) 686-693
18. Gillham G.M., Aherne N., Rowley S., et al. Quality of life and survival in patients treated with radical chemoradiation alone for oesophageal cancer. Clin Oncol 20 (2008) 227-233
19. Bonnetain F., Bouché O., Michel P., et al. A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic esophageal cancer. Ann Oncol 17 (2006) 827-834
20. Denham J.W., Steigler A., Kilmurray J., et al. Relapse patterns after chemo-radiation for carcinoma of the oesophagus. Clin Oncol 15 (2003) 98-108
21. Ryan P., McCarthy S., Kelly J., et al. Prevalence of bone marrow micrometastases in esophagogastric cancer patients with and without neoadjuvant chemoradiotherapy. J Surg Res 117 (2004) 121-126
22. Dresner S.M., and Griffin S.M. Pattern of recurrence following radical oesophagectomy with two-field lymphadenectomy. Br J Surg 87 (2000) 1426-1433
23. Chiu P.W., Chan A.C., Leung S.F., et al. Multicenter prospective randomized trial comparing standard esophagectomy with chemoradiotherapy for treatment of squamous esophageal cancer: early results from the Chinese University Research Group for Esophageal Cancer (CURE). J Gastrointest Surg 9 (2005) 794-802
24. Yu J., Ren R., Sun X., Yin Y., and Fu Z. A randomized clinical study of surgery versus radiotherapy in the treatment of resectable esophageal cancer. J Clin Oncol 24 18S (2006) A4013
25. Carstens H., Albertsson M., Friesland S., et al. A randomized trial of chemoradiotherapy versus surgery alone in patients with resectable esophageal cancer. J Clin Oncol 25 18S (2007) A4530
26. Siewert J.R., Stein H.J., Feith M., et al. Tumor cell type is an independent prognostic parameter in esophageal cancer: lessons learned from more than 1000 consecutive resections at a single institution in the Western world. Ann Surg 234 (2001) 360-369
27. SCOPE 1: Study of Chemotherapy in Oesophageal Cancer Plus or Minus Erbitux. Available from:. http://www.wctu.org.uk/scopeh.htm
28. Thirion P.G., Michiels S.A., Le Maître J., and Tierney J. on behalf of the MetaAnalysis of Chemotherapy in Esophagus Cancer Collaborative Group. Individual patient data-based meta-analysis assessing pre-operative chemotherapy in resectable oesophageal carcinoma. J Clin Oncol 25 18S (2007) A4512
29. Neoptolemos J.P., Stocken D.D., Friess H., et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 350 (2004) 1200-1210
30. Hallisey M.T., Dunn J.A., Ward L.C., et al. The second British Stomach Cancer Group trial of adjuvant radiotherapy or chemotherapy in resectable gastric cancer: five year follow-up. Lancet 343 (1994) 1309-1312